Tranexamic Acid and Blood Loss During and After Cesarean Section: A Prospective Randomized Study
Keywords:
Tranexamic acid, Blood loss, Cesarean sectionAbstract
Objective: To find out the effectiveness and safety of tranexamic acid in the reduction of blood loss during and after the cesarean section.
Methodology: A prospective, randomized, placebo controlled, study was directed on 100 women experiencing lower segment cesarean segment (LSCS) at Department of Obstetrics and Gynecology, Combined Military Hospital Muzaffarabad over 6 months from May 2018 to October 2018. Fifty of them were given tranexamic acid preceding LSCS were contrasted and 50 control group who got IV placebo. Blood loss was collected and estimated during two periods. The study group got IV tranexamic acid and the control group got IV placebo. Following delivery, all participants got 10 units of oxytocin in 500 mL of normal saline. Hemoglobin, urine examination, liver and renal functions were checked in both the groups.
Results: Tranexamic acid essentially decreased the quantity of blood loss from the finish of LSCS to 2 hours postpartum: 60.96±13.4 ml in the investigation group versus 112.02±13.46 mL in the control group (p=0.001). It additionally essentially reduced the amount of blood loss– Intraoperative 500.62±111.20 mL in the study group, versus 696.85±196.32 ml in the control group. (P<0.001). No serious complication or reactions were accounted for in either group.
Conclusion: Tranexamic acid essentially decreased the quantity of blood loss during and after the lower segment cesarean segment and its utilization was not associated with any serious reactions or side effect like thrombosis. TXA can be utilized as safe and effective in participants undergoing LSCS and useful for anemic women or the individuals who refuse blood transfusion
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Noshina Shabir; Hina Pirzada, Shafaq Hanif, Rubina Rafique
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
